Medicinal Product Shortages – update – 16 March 2022

Notice type: Advisory

Date: 16/03/2022

 

Further Information:

 The Health Products Regulatory Authority has been notified of a shortage of the following products:

  • Boostrix Suspension for Injection in a Pre Filled Syringe - PA1077/020/001
  • Calvepen 666mg Tablets - PA0126/137/002
  • Diflucan 50mg Capsules - PA0822/211/001
  • Geodon 80mg Hard Capsules - PA23055/015/004
  • Oestrogel Pump-Pack 750mcg/actuation Gel - PA1054/004/001
  • Six Plus Parapaed Paracetamol Oral Suspension 250mg/5ml - PA0281/002/003
  • Suboxone 2mg/0.5mg Sublingual Tablet - EU/1/06/359/002
  • Suboxone 8mg/2mg Sublingual Tablet - EU/1/06/359/004
  • Typhim Vi 0.5 ml Solution for Injection, Typhoid Polysaccharide Vaccine - PA2131/011/001

 

The following shortages have been resolved and supply has resumed to the Irish market:

  • Aripiprazole 15mg Tablets - PA1986/019/003
  • Flucol 50mg Hard Capsules - PA0711/057/001
  • Hyaluronidase 1500IU Powder for Solution for Injection or Infusion - PA0281/231/001
  • Piriton 4mg Tablets - PA0678/080/001
  • Salamol Steri-Neb 2.5 mg/2.5 ml Nebuliser Solution - PA1986/086/001
  • Targin 30mg/15mg Prolonged Release Tablet - PA1688/010/007
  • Telmisartan Rowa 40mg Tablets-PA0074/078/002
  • Temodal 5mg Capsules - EU/1/98/096/024
  • Xatger 10mg Prolonged Release Tablets - PA0577/079/002

 

Please see the shortages section of the HPRA website for further information.

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.




« Back